| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $53.7M | — |
| R&D Expense | $19.2M | -60.2% |
| SG&A Expense | $17.7M | -1.6% |
| Operating Income | $16.9M | +125.6% |
| Pre-tax Income | $29.8M | +164.7% |
| Income Tax | $0 | -100.0% |
| Net Income | $29.8M | +162.5% |
| EPS (Basic) | $2.42 | +147.3% |
| EPS (Diluted) | $2.42 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.3M | -38.1% |
| Current Assets | $55.0M | -32.8% |
| Total Assets | $61.8M | -33.1% |
| Current Liabilities | $11.3M | -31.1% |
| Total Liabilities | $19.8M | -77.2% |
| Stockholders' Equity | $42.0M | +640.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.5M | +50.5% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $7.0M | -64.9% |
| Financing Cash Flow | -$3.1M | -103.3% |
| Free Cash Flow | -$33.5M | +50.5% |
| +136.8% |